Novartis
NVS
#57
Rank
โ‚ฌ217.78 B
Marketcap
113,50ย โ‚ฌ
Share price
-0.20%
Change (1 day)
21.95%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Revenue for Novartis (NVS)

Revenue in 2025 (TTM): โ‚ฌ50.43 Billion

According to Novartis's latest financial reports the company's current revenue (TTM ) is โ‚ฌ48.41 Billion. In 2024 the company made a revenue of โ‚ฌ49.70 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ42.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novartis from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ50.43 B1.48%
2024 โ‚ฌ49.70 B17.76%
2023 โ‚ฌ42.20 B-9.03%
2022 โ‚ฌ46.39 B-0.63%
2021 โ‚ฌ46.69 B15.09%
2020 โ‚ฌ40.56 B-6.64%
2019 โ‚ฌ43.45 B3.85%
2018 โ‚ฌ41.84 B0.14%
2017 โ‚ฌ41.78 B-11.1%
2016 โ‚ฌ46.99 B1.99%
2015 โ‚ฌ46.08 B4.5%
2014 โ‚ฌ44.09 B9.23%
2013 โ‚ฌ40.37 B-7.22%
2012 โ‚ฌ43.51 B-4.82%
2011 โ‚ฌ45.72 B17.95%
2010 โ‚ฌ38.76 B23.13%
2009 โ‚ฌ31.48 B3.35%
2008 โ‚ฌ30.46 B14.74%
2007 โ‚ฌ26.54 B0.08%
2006 โ‚ฌ26.52 B-3.17%
2005 โ‚ฌ27.39 B31.56%
2004 โ‚ฌ20.82 B5.44%
2003 โ‚ฌ19.74 B-11.47%
2002 โ‚ฌ22.30 B1.22%
2001 โ‚ฌ22.04 B-0.26%
2000 โ‚ฌ22.09 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
โ‚ฌ55.16 B 13.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 11.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.13 B 63.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.81 B-15.69%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ36.37 B-24.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B-70.24%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ37.65 B-22.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.91 B 3.11%๐Ÿ‡ฌ๐Ÿ‡ง UK